COMMENTARY ON: ASPARTATE TRANSAMINASE TO PLATELET RATIO INDEX (APRI): A SIMPLE NONINVASIVE INDEX ASSESSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASES (LETTER TO EDITOR)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MAO YILEI; HUANG JIUZUO

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2011 | Volume:11 | Issue:5 (34) Page(s): 376-377

Download Full-Text

View:

313

Download:

175

Cites:

Information Journal Paper

Title

COMMENTARY ON: ASPARTATE TRANSAMINASE TO PLATELET RATIO INDEX (APRI): A SIMPLE NONINVASIVE INDEX ASSESSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASES (LETTER TO EDITOR)

Author(s)

MAO YILEI | HUANG JIUZUO | Issue Writer Certificate

Keywords

CHRONIC HEPATITIS B

NAFLD

LIVER FIBROSIS

CHRONIC HEPATITIS C

Abstract

Hepatitis Monthly has recently published an interesting and practically valuable original report from Yilmaz, et al.(1). That was a retrospective study investigating the ability of the aspartate transaminase to platelet ratio index (APRI) in diagnosing and predicting the extent of fibrosis in patients with CHRONIC HEPATITIS B (CHB), CHRONIC HEPATITIS C (CHC), and non-alcoholic fatty liver disease (NAFLD). This relatively large scale study was conducted on a cohort of 207 CHB patients, 108 CHC patients, and 140 NAFLD patients. The results of that study were apparently reliable and potentially useful with clinical significance.The authors, by comparing with the results from liver biopsy, concluded that APRI has an acceptable accuracy for the assessment of the extent of LIVER FIBROSIS in patients with CHC and NAFLD, but not in those with CHB.

Cites

No record.

References

No record.

Cite

APA: Copy

MAO, YILEI, & HUANG, JIUZUO. (2011). COMMENTARY ON: ASPARTATE TRANSAMINASE TO PLATELET RATIO INDEX (APRI): A SIMPLE NONINVASIVE INDEX ASSESSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASES (LETTER TO EDITOR). HEPATITIS MONTHLY, 11(5 (34)), 376-377. SID. https://sid.ir/paper/306402/en

Vancouver: Copy

MAO YILEI, HUANG JIUZUO. COMMENTARY ON: ASPARTATE TRANSAMINASE TO PLATELET RATIO INDEX (APRI): A SIMPLE NONINVASIVE INDEX ASSESSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASES (LETTER TO EDITOR). HEPATITIS MONTHLY[Internet]. 2011;11(5 (34)):376-377. Available from: https://sid.ir/paper/306402/en

IEEE: Copy

YILEI MAO, and JIUZUO HUANG, “COMMENTARY ON: ASPARTATE TRANSAMINASE TO PLATELET RATIO INDEX (APRI): A SIMPLE NONINVASIVE INDEX ASSESSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASES (LETTER TO EDITOR),” HEPATITIS MONTHLY, vol. 11, no. 5 (34), pp. 376–377, 2011, [Online]. Available: https://sid.ir/paper/306402/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops